Stock To Watch: OraSure Technologies (OSUR) In Perilous Reversal

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified OraSure Technologies ( OSUR) as a "perilous reversal" (up big yesterday but down big today) candidate. In addition to specific proprietary factors, Trade-Ideas identified OraSure Technologies as such a stock due to the following factors:

  • OSUR has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $15.6 million.
  • OSUR has traded 767,514 shares today.
  • OSUR is down 3.8% today.
  • OSUR was up 23.9% yesterday.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in OSUR with the Ticky from Trade-Ideas. See the FREE profile for OSUR NOW at Trade-Ideas

More details on OSUR:

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. OSUR has a PE ratio of 275. Currently there are 6 analysts that rate OraSure Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

The average volume for OraSure Technologies has been 664,900 shares per day over the past 30 days. OraSure has a market cap of $309.7 million and is part of the health care sector and health services industry. The stock has a beta of 1.60 and a short float of 3.6% with 0.76 days to cover. Shares are down 45.9% year-to-date as of the close of trading on Friday.

If you liked this article you might like

Stocks Under $10 Portfolio: Not Resting on Our Laurels

How to Cash in on the Fight Against the Zika Virus

OraSure (OSUR) Stock Spikes, Upgraded at Stephens

4 Stocks for Fighting Zika

OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract